000			02324 a2200649 4500
005			20250517123932.0
264		0	_c20180205
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.13180 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhou, Mingge
245	0	0	_aPrognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma. _h[electronic resource]
260			_bOncotarget _cDec 2016
300			_a83544-83553 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aChi-Square Distribution
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorodeoxyglucose F18 _xadministration & dosage
650	0	4	_aGlycolysis _xdrug effects
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnostic imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aPositron Emission Tomography Computed Tomography _xmethods
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProportional Hazards Models
650	0	4	_aRadiopharmaceuticals _xadministration & dosage
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aVincristine _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aChen, Yumei
700	1		_aHuang, Honghui
700	1		_aZhou, Xiang
700	1		_aLiu, Jianjun
700	1		_aHuang, Gang
773	0		_tOncotarget _gvol. 7 _gno. 50 _gp. 83544-83553
856	4	0	_uhttps://doi.org/10.18632/oncotarget.13180 _zAvailable from publisher's website
999			_c26596526 _d26596526